Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Schleiermacher, G"'
Publikováno v:
Oncogene. 3/18/2010, Vol. 29 Issue 11, p1566-1579. 14p. 3 Diagrams, 1 Graph.
Autor:
Schleiermacher, G.1,2 gudrun.schleiermacher@curie.net, Michon, J.2, Huon, I.3, d'Enghien, C. Dubois3, Klijanienko, J.4, Brisse, H.5, Ribeiro, A.3, Mosseri, V.6, Rubie, H.7, Munzer, C.7, Thomas, C.8, Valteau-Couanet, D.9, Auvrignon, A.10, Plantaz, D.11, Delattre, O.1, Couturier, J.1,3, Société Française des Cancers de l'Enfant (SFCE) (CORPORATE AUTHOR)
Publikováno v:
British Journal of Cancer. 7/16/2007, Vol. 97 Issue 2, p238-246. 9p. 2 Diagrams, 5 Charts, 2 Graphs.
Autor:
Geeta G. Sharma, Sorcha Forde, Hélène Pacquement, Ivonne A. Montes-Mojarro, Ralf Jauch, Wolfram Klapper, Cosimo Lobello, Liam C. Lee, Luca Mologni, Anne Lambilliotte, Suzanne D. Turner, Laurence Brugières, Roberto Chiarle, Stephen P. Ducray, Jamie D. Matthews, Birgit Geoerger, Shahid Pervez, Carlo Gambacorti-Passerini, Lukas Kenner, Šárka Pospíšilová, Klaas Bahnsen, Shi-Lu Luan, Nina Prokoph, Andrea Janíková, G. A. Amos Burke, Olaf Merkel, Huan-Chang Liang, Elif Karaca-Atabay, Hugo Larose, Wilhelm Woessmann, Qi Wang, Andishe Attarbaschi, Jack M. Monahan, Vikas Malik, Judith Landman-Parker, Isaia Barbieri, Gilles Vassal, Gudrun Schleiermacher, Nicola A. Probst
Anaplastic large cell lymphoma (ALCL) is a T-cell malignancy predominantly driven by a hyperactive anaplastic lymphoma kinase (ALK) fusion protein. ALK inhibitors, such as crizotinib, provide alternatives to standard chemotherapy with reduced toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae853e045a135b7e317c7f6be0735d41
https://www.repository.cam.ac.uk/handle/1810/305799
https://www.repository.cam.ac.uk/handle/1810/305799